GEM联合CBP与NVB联合DDP治疗老年NSCLC对比研究

蒋幼凡; 王导新; 兰箭

您当前的位置：

首页 >

文章列表页 >

GEM联合CBP与NVB联合DDP治疗老年NSCLC对比研究

更新时间：2024-01-17

- GEM联合CBP与NVB联合DDP治疗老年NSCLC对比研究
- Comparative study of gemcitabine plus CBP and navelbine plus DDP regimen in the treatment of old patients with age NSCLC
- 重庆医科大学学报 2006年第1期页码：85-87
- 作者机构：
  
  1. 重庆医科大学附属第二医院呼吸科
  2. 重庆医科大学附属第二医院呼吸科,重庆,400010
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R734.2
- 纸质出版日期：2006，
扫描看全文
[1]蒋幼凡,王导新,兰箭.GEM联合CBP与NVB联合DDP治疗老年NSCLC对比研究[J].重庆医科大学学报,2006(01):85-87.

JIANG Youfan, et al. Comparative study of gemcitabine plus CBP and navelbine plus DDP regimen in the treatment of old patients with age NSCLC[J]. Journal of Chongqing Medical University, 2006,(1):85-87.
[1]蒋幼凡,王导新,兰箭.GEM联合CBP与NVB联合DDP治疗老年NSCLC对比研究[J].重庆医科大学学报,2006(01):85-87. DOI：

JIANG Youfan, et al. Comparative study of gemcitabine plus CBP and navelbine plus DDP regimen in the treatment of old patients with age NSCLC[J]. Journal of Chongqing Medical University, 2006,(1):85-87. DOI：

摘要

目的:对比观察吉西他滨（Gem citabine

GEM）联合卡铂（CBP）及长春瑞滨（NVB）联合顺铂（DDP）方案在晚期老年非小细胞肺癌临床疗效及毒性反应。方法:40例晚期老年（大于60岁）肺非小细胞肺癌

被随机分为两组为吉西他滨+卡铂组20例

长春瑞滨+顺铂组20例。吉西他滨1000m g/m 2

d1、d8

卡铂300m g/m 2

第1天

每3周为1周期;长春瑞堂皇m g/m 2 d1、d8

顺铂的剂量80m g/m 2

分第1、3两天用

每3周为1周期。结果:吉西他滨组有效率（CR+PR）为40%

长春瑞滨组有效率（CR+PR）为35%

有效率两组间差异无显著性（P>0.05）。中位生存期（M ST）、疾病缓解时间（DPT）、一年生存率两组间均无显著性差异（P>0.05）。但吉西他滨组血小板下降及静脉炎的发生率显著低于长春瑞滨组。结论:吉西他滨联合卡铂与长春瑞滨联合顺铂对晚期老年非小细胞肺癌的近期临床效相近

中位生存期、疾病缓解时间、一年生存率均相似

但GEM+CBP毒性反应低于NVB+DDP

GC方案可作为治疗晚期老年非小细胞肺癌的一种安全、有效的化疗方案。

Abstract

Objective: To evaluate and compare the effects and safety of GC(GEZ+CBP) regimen and NP(NVB=DDP) regimen for old age patients with advancde non-small cell lung cancer(NSCLC).Methods: The 40 cases of old age patients with advancde NSCLC were randomly divided into GC regimen group and NP regimen group

twenty cases of each group respectively received GEM+CBP regimen and NVB+DDP regimen.The patients received GEM 1000mg/m2 on 1st and 8th day and CBP 300 mg/m2 on 1st day.NVB 25mg/m2 on 1st and 8th day and DDP 80mg/m2 with 1st and 3th day.Course was repeated every 3 weeks.Results: The response rate(CR+PR) were 40% and 35% respectively for GEM and NVB groups.There was no significant difference existed between the two groups(P>0.05)

and also the MST

DPT and one-year survival rate(P>0.05).But the rates of thrombocytopenia and phlebitis in GEM group were significantly lower than NVB group.Conclusions: The short-time clinical efficacy

MST

DPT and one-year survival rate of GEM+CBP regimen were similar to those of NVB+DDP regimen

but the toxicity of GEM+CBP regimen were lower than those of NVB+DDP regimen.The GC regimen is a safe and effective regimen for old age advancde NSCLC.

关键词

非小细胞肺癌吉西他滨长春瑞滨老年化疗

Keywords

non-small cell lung cancergemcitabineNavelbineElderly patientschemotherapy

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

异环磷酰胺、长春酰胺和顺铂联合治疗晚期非小细胞肺癌

不同剂量吉西他滨辅助化疗根治术后胰腺癌的随机对照临床研究

免疫治疗在EGFR突变非小细胞肺癌中的研究进展

维迪西妥单抗和术后化疗用于治疗人表皮生长因子受体2阳性的局限性尿路上皮癌患者的临床疗效分析

经尿道膀胱肿瘤黏膜下剥离术联合术中膀胱黏膜下注射吉西他滨治疗膀胱非肌层浸润性尿路上皮癌的疗效观察（附7例报告）